COVID-19 Vaccine (Corbevax)

Corbevax is a protein subunit vaccine developed by Biological E Ltd in collaboration with Texas Children's Hospital and Baylor College of Medicine. It uses the receptor-binding domain (RBD) of the spike protein.

The COVID-19 Vaccine (Corbevax) is recommended for 12 years and above. It falls under the COVID-19 vaccine category. Consult your doctor to confirm if this vaccine is right for you based on your health history and existing immunity.

The COVID-19 Vaccine (Corbevax) has an efficacy of 90% against Delta variant; strong antibody response. This means it provides significant protection against COVID-19 and Severe COVID-19 disease. Efficacy may vary based on age, health status, and the specific strain encountered.

Common side effects include: Injection site pain; fatigue; headache; mild fever. These are typically mild and resolve within 1–3 days. Serious allergic reactions are rare — if you experience difficulty breathing, hives, or rapid heartbeat after vaccination, seek emergency care immediately.

The COVID-19 Vaccine (Corbevax) should be avoided by: Severe allergic reaction to prior dose or vaccine components.. Always inform your healthcare provider of your full medical history before vaccination.

The COVID-19 Vaccine (Corbevax) typically costs Free at government centres; ₹250–₹400 private in India. Government health centres may offer it free or at subsidised prices for eligible age groups. Private hospitals and clinics may charge differently. Additional fees may apply for administration.